OpenEvidence
Launched during the Mayo Clinic Platform Accelerate program and featured by the New England Journal of Medicine AI, OpenEvidence is the world’s leading medical AI.
OpenEvidence
OpenEvidence, powered by Xyla Inc., is an AI-driven medical information platform providing synthesized, evidence-based content to healthcare professionals for improved clinical decision-making.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
AI technology
Data collection and analysis tools
Content management systems
Data security solutions
Data analytics tools
State-of-the-art technology to sift through millions of documents
Service Requirements
Ongoing maintenance and support for AI platforms and data infrastructure
Data analytics services
Advertising management services
Market research services
Customer support
Infrastructure Requirements
Servers
Databases
Network infrastructure
Secure data storage
Robust servers
Scalable data storage
Efficient content delivery network
Mobile applications
Talent Requirements
AI specialists
Data scientists
Medical content curators
Software developers
Compliance experts
AI Insights
Growth Trajectory
With hundreds of thousands of verified doctors and growing, OpenEvidence exhibits significant growth potential as a leading medical information platform.
Market Opportunity
OpenEvidence is positioned to capitalize on the increasing demand for accessible, synthesized medical information, addressing the information overload challenge within the healthcare industry.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats